- Home
- FUN vs ALKS Comparison
FUN vs ALKS Comparison
Compare FUN & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUN
- ALKS
- Stock Information
- Founded
- FUN 1983
- ALKS 1987
- Country
- FUN United States
- ALKS Ireland
- Employees
- FUN N/A
- ALKS N/A
- Industry
- FUN Services-Misc. Amusement & Recreation
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- FUN Consumer Discretionary
- ALKS Health Care
- Exchange
- FUN Nasdaq
- ALKS Nasdaq
- Market Cap
- FUN 4.6B
- ALKS 4.8B
- IPO Year
- FUN 1987
- ALKS 1991
- Fundamental
- Price
- FUN $45.77
- ALKS $27.70
- Analyst Decision
- FUN Strong Buy
- ALKS Buy
- Analyst Count
- FUN 13
- ALKS 12
- Target Price
- FUN $55.92
- ALKS $35.42
- AVG Volume (30 Days)
- FUN 1.4M
- ALKS 2.0M
- Earning Date
- FUN 11-06-2024
- ALKS 10-24-2024
- Dividend Yield
- FUN 2.63%
- ALKS N/A
- EPS Growth
- FUN N/A
- ALKS 55.25
- EPS
- FUN 0.37
- ALKS 1.97
- Revenue
- FUN $2,392,739,000.00
- ALKS $1,505,121,000.00
- Revenue This Year
- FUN $84.47
- ALKS N/A
- Revenue Next Year
- FUN $4.04
- ALKS N/A
- P/E Ratio
- FUN $125.05
- ALKS $14.10
- Revenue Growth
- FUN 33.41
- ALKS N/A
- 52 Week Low
- FUN $35.93
- ALKS $22.22
- 52 Week High
- FUN $58.70
- ALKS $32.88
- Technical
- Relative Strength Index (RSI)
- FUN 66.84
- ALKS 48.06
- Support Level
- FUN $44.90
- ALKS $27.11
- Resistance Level
- FUN $47.52
- ALKS $28.29
- Average True Range (ATR)
- FUN 1.53
- ALKS 0.90
- MACD
- FUN 0.11
- ALKS -0.09
- Stochastic Oscillator
- FUN 72.65
- ALKS 37.35
About FUN Cedar Fair L.P.
Six Flags Entertainment Corp is North America's regional amusement-resort operator with 27 amusement parks, 15 water parks and nine resort properties across 17 states in the U.S., Canada and Mexico. Six Flags provides coasters, themed rides, thrilling water parks, resorts and a portfolio of beloved intellectual property such as Looney Tunes, DC Comics and PEANUTS.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.